Results 151 to 160 of about 231,458 (256)

Meditope-Enabled Chimeric Antigen Receptors Facilitate Plug-and-Play Control of T Cells. [PDF]

Cancer Immunol Res
Kuo CF, Tong Z, Kuo YC, Park M, King J, Ly K, Parcutela B, Stern LA, Wang Z, Hibbard JC, Aguilar B, Starr R, Chang WC, Ostberg JR, Rossi D, Clark MC, Alizadeh D, Forman SJ, Williams JC, Brown CE.   +19 more
europepmc   +1 more source

Chimeric antigen receptor T cell therapy in autoimmune neurological disease: current status of efficacy and safety. [PDF]

BMJ Neurol Open
Bradhurst P, Hardy TA, Riminton S.
europepmc   +1 more source

In the Midst of a Cytokine Storm—The Hemophagocytic Syndrome (Hemophagocytic Lymphohistiocytosis/Macrophage Activation Syndrome)

Veterinary Clinical Pathology, EarlyView.
ABSTRACT Background Hemophagocytic syndrome (HPS)/hemophagocytic lymphohistiocytosis (HLH) is a life‐threatening hyperinflammatory syndrome characterized by immune dysregulation, cytokine overproduction, hemophagocytosis, cytopenias, and multiorgan dysfunction.
Joanne B. Messick
wiley   +1 more source

Development of tandem canine CAR T cells to enable comparative studies of aggressive B-cell lymphoma. [PDF]

Mol Cancer Ther
Peng B, Jiang L, Lenz JA, Cesar Conti L, Rotolo A, Mason NJ, Atherton MJ.   +6 more
europepmc   +1 more source

Nodal T Follicular Helper Cell Lymphoma With Epstein–Barr Virus‐Positive Neoplastic T Cells Derived From Clonal Hematopoiesis

eJHaem, Volume 7, Issue 6, December 2026.
ABSTRACT Introduction Nodal T follicular helper cell lymphoma (nTFHL) with Epstein–Barr virus (EBV)‐positive neoplastic T cells is rare. Methods We report a woman with nTFHL and analyzed EBV‐infected cells using an immunobead‐based method and assessed somatic mutations in lymphoma and lymphoma‐uninvolved bone marrow by targeted sequencing.
Daichi Kishi, Nobuhiro Hiramoto, Daisuke Yamashita, Hayato Maruoka, Yumi Shiroishi, Masashi Nishikubo, Yoshimitsu Shimomura, Ryusuke Yamamoto, Yuya Nagai, Yuka Torii, Hiroshi Kimura, Yasuhito Nannya, Seishi Ogawa, Tadakazu Kondo   +13 more
wiley   +1 more source

Antibody-Based Therapeutics in Autoimmune Diseases: Mechanisms, Challenges, and Future Perspectives. [PDF]

Int J Mol Sci
Mahroum N.
europepmc   +1 more source

Characteristics and Outcomes of Male Participants in a Multicenter Longitudinal Australian Study Cohort

Arthritis Care &Research, Volume 78, Issue 11, Page 1701-1710, November 2026.
Objective The aim of this study was to determine the differences in demographic, serologic, and clinical characteristics between male and female patients with systemic sclerosis (SSc) in an Australian cohort. Methods This was a retrospective observational study using data from the Australian Scleroderma Cohort Study.
Emily Lin, Dylan Hansen, Laura Ross, Gene‐Siew Ngian, Susanna Proudman, Gabor Major, Maryam Tabesh, Mandana Nikpour, Jennifer Walker, Lauren Host, Nava Ferdowsi, Alannah Quinlivan, Wendy Stevens, Joanne Sahhar, Diane Apostolopoulos   +14 more
wiley   +1 more source

Multi-antigen chimeric antigen receptor-T cell therapy for relapsed/refractory B cell lymphomas. [PDF]

Front Immunol
Pandey T, Samat D, Dahiya S, Patel SA.
europepmc   +1 more source

Targeting B‐Cell‐Activating Factor and Its Receptor in Immune Thrombocytopenia and Warm Autoimmune Hemolytic Anemia

American Journal of Hematology, Volume 101, Issue 11, Page 2836-2852, November 2026.
ABSTRACT Current treatments for immune thrombocytopenia (ITP) and warm autoimmune hemolytic anemia (wAIHA), rare autoimmune diseases in which autoreactive B cells play a major role, can lead to high response rates; however, for many patients these responses are not durable or maintained after treatment discontinuation.
Matthieu Mahévas, Nichola Cooper, Vickie McDonald, Karina Yazdanbakhsh, Wilma Barcellini   +4 more
wiley   +1 more source

Cancer cell-selective ectopic expression of CD20 as an antigen enables rituximab repurposing for solid tumour immunotherapy. [PDF]

Clin Transl Med
Kong Z, Wang Y, Zhao Y, Wang L, Fan Z, Shu Y, Wang J.   +6 more
europepmc   +1 more source